Landscape → Dermatology

Acne Clinical Trial Landscape

Data updated: May 20, 2026

392 clinical trials tracked since 2008

Acne is being studied across 392 clinical trials registered since 2008, with 40 programs currently active. The competitive pipeline includes 13 active Phase 3 trials, 16 active Phase 2 trials, and 8 active Phase 1 trials. Top industry sponsors include AbbVie, Sanofi, Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd..

40 active

392 total (since 2008)

Phase 1 Active

95 total

Phase 2 Active

120 total

Phase 3 Active

112 total

Phase 4 Active

95 total

Top Industry Sponsors

Sorted by active Active Done Failed

AbbVie 2 6 2

Sanofi 2 1 0

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. 2 1 0

Galderma R&D 1 37 0

Bausch Health Americas, Inc. 1 24 0

+ 10 more sponsors — see full table below

Featured Phase 3 Trials

NCT05995340 ACTIVE NOT RECRUITING

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

AbbVie n=157

NCT07389109 ACTIVE NOT RECRUITING

A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)

PPM Services S.A. n=400

NCT07384208 ACTIVE NOT RECRUITING

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)

PPM Services S.A. n=400

NCT07384195 ACTIVE NOT RECRUITING

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)

PPM Services S.A. n=400

NCT07207369 RECRUITING

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

AbbVie n=395

+ 107 more Phase 3 trials — see full database below

Acne — Trials Started by Year (last 10 years)

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

TheraRadar.com

Full Trial Database

Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.

Top Sponsors (all-time)

AbbVie

Sanofi

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

Galderma R&D

Bausch Health Americas, Inc.

Sun Pharmaceutical Industries Limited

Integrative Skin Science and Research

Shanghai Huaota Biopharmaceutical Co., Ltd.

Sagimet Biosciences Inc.

Jiangxi Kvvit Pharmaceutical Co., Ltd.

Active Trials by Phase

Phase 1

Phase 2

Phase 3

Phase 4

Enrollment Size Distribution

1-50

129

51-200

113

201-500

501-1k

1k+

All Industry Sponsors

Sorted by active Active Done Failed

AbbVie 2 6 2

Sanofi 2 1 0

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. 2 1 0

Galderma R&D 1 37 0

Bausch Health Americas, Inc. 1 24 0

Sun Pharmaceutical Industries Limited 1 6 0

Integrative Skin Science and Research 1 0 0

Shanghai Huaota Biopharmaceutical Co., Ltd. 1 0 0

Sagimet Biosciences Inc. 1 0 0

Jiangxi Kvvit Pharmaceutical Co., Ltd. 1 0 0

Biofrontera Inc. 1 0 0

Eurofarma Laboratorios S.A. 1 0 0

Equipmed USA LLC 1 0 0

Stiefel, a GSK Company 0 23 0

Sun Pharmaceutical Industries, Inc. 0 17 0

NCT05995340 ACTIVE NOT RECRUITING

ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars

AbbVie n=157

NCT07389109 ACTIVE NOT RECRUITING

A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)

PPM Services S.A. n=400

NCT07384208 ACTIVE NOT RECRUITING

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)

PPM Services S.A. n=400

NCT07384195 ACTIVE NOT RECRUITING

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)

PPM Services S.A. n=400

NCT07457294 NOT YET RECRUITING

1% Clascoterone Cream for the Treatment Acne Vulgaris

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. n=692

NCT07207369 RECRUITING

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

AbbVie n=395

NCT07186413 RECRUITING

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

Galderma R&D n=561

NCT06787222 ACTIVE NOT RECRUITING

Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome

Hasanuddin University n=26

NCT06403501 RECRUITING

Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. n=692

NCT06905210 NOT YET RECRUITING

Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

Eurofarma Laboratorios S.A. n=526

NCT06447480 RECRUITING

Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients

Centre Hospitalier Universitaire de Nice n=420

NCT06775314 NOT YET RECRUITING

The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Salicylic Acid 0,5%, Zinc Lactate, Hyaluronic Acid and Spot Cream Containing Triethyl Citrate, Ethyl Linoleate, GT Peptide-10, Honokiol

Dr.dr.Irma Bernadette, SpKK (K) n=102

NCT06602284 NOT YET RECRUITING

A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks.

Equipmed USA LLC n=10

NCT06248008 COMPLETED

A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris

Ascletis Pharmaceuticals Co., Ltd. n=240

NCT05608499 TERMINATED

Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

Icahn School of Medicine at Mount Sinai n=15

NCT06090721 COMPLETED

DMT310-009 Topical in the Treatment of Acne Vulgaris

Dermata Therapeutics n=520

NCT06192264 COMPLETED

A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris

Ascletis Pharmaceuticals Co., Ltd. n=480

NCT06242288 COMPLETED

Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris

Mostafa Bahaa n=40

NCT05550337 COMPLETED

Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulgaris

Teva Pharmaceuticals USA n=807

NCT06451237 COMPLETED

Acne Remission Maintenance by Weekend Systemic Isotretinoin

Alexandria University n=60

NCT04214639 COMPLETED

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=183

NCT04214652 COMPLETED

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=180

NCT04960930 COMPLETED

To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

Cutia Therapeutics (Shanghai) Co., Ltd n=372

NCT02667444 COMPLETED

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

Novan, Inc. n=1,330

NCT02672332 COMPLETED

P3 Study in Acne Comparing Once Daily SB204 and Vehicle

Novan, Inc. n=1,307

NCT03334682 COMPLETED

Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.

Nantes University Hospital n=158

NCT02798120 COMPLETED

P3 Long Term Safety Study of Once Daily SB204 in Acne

Novan, Inc. n=601

NCT03664752 COMPLETED

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=585

NCT03664739 COMPLETED

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=608

NCT05629468 COMPLETED

Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris

Pak Emirates Military Hospital n=75

NCT05573425 COMPLETED

Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars

Jinnah Postgraduate Medical Centre n=202

NCT02832063 COMPLETED

Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris

AOBiome LLC n=372

NCT02815280 COMPLETED

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Vyne Therapeutics Inc. n=495

NCT03271021 COMPLETED

A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris

Vyne Therapeutics Inc. n=1,488

NCT02815267 COMPLETED

A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne

Vyne Therapeutics Inc. n=466

NCT03761810 COMPLETED

A Study of S6G5T3 in the Treatment of Acne Vulgaris

Sol-Gel Technologies, Ltd. n=434

NCT03761784 COMPLETED

A Study of S6G5T-3 in the Treatment of Acne Vulgaris

Sol-Gel Technologies, Ltd. n=424

NCT03915860 COMPLETED

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Galderma R&D n=47

NCT03393494 COMPLETED

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

Padagis LLC n=825

NCT02515305 COMPLETED

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Padagis LLC n=890

NCT02525549 COMPLETED

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Padagis LLC n=903

NCT01796665 COMPLETED

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Padagis LLC n=1,180

NCT01138514 COMPLETED

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

Padagis LLC n=1,555

NCT03073486 COMPLETED

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Dermira, Inc. n=744

NCT03127956 COMPLETED

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Dermira, Inc. n=748

NCT03028363 COMPLETED

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Dermira, Inc. n=759

NCT03717506 COMPLETED

Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris

Balmoral Medical company n=1,236

NCT03168334 COMPLETED

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)

Bausch Health Americas, Inc. n=801

NCT03168321 COMPLETED

A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

Bausch Health Americas, Inc. n=813

NCT03290027 COMPLETED

A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris

Dr. Reddy's Laboratories Limited n=550

NCT03292640 COMPLETED

A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks

Dr. Reddy's Laboratories Limited n=547

NCT00883233 COMPLETED

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris

Galderma R&D n=123

NCT01474590 COMPLETED

Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne

Galderma R&D n=266

NCT02932267 COMPLETED

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne

Galderma R&D n=50

NCT00687908 COMPLETED

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

Galderma R&D n=243

NCT00688064 COMPLETED

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

Galderma R&D n=459

NCT01014689 COMPLETED

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris

Galderma R&D n=378

NCT04249128 COMPLETED

Nourishing Hair, Skin & Nails Supplement Study (Derm Aid)

ProofPilot n=75

NCT02608476 COMPLETED

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

Cassiopea SpA n=732

NCT02608450 COMPLETED

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

Cassiopea SpA n=708

NCT02682264 COMPLETED

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

Cassiopea SpA n=609

NCT02005666 COMPLETED

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Zydus Lifesciences Limited n=850

NCT03522441 COMPLETED

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Akorn, Inc. n=1,125

NCT04329403 WITHDRAWN

Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%

Aurobindo Pharma Ltd

NCT02651220 COMPLETED

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Actavis Inc. n=1,001

NCT02267746 COMPLETED

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

Actavis Inc. n=893

NCT02616614 COMPLETED

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Actavis Inc. n=862

NCT03615768 COMPLETED

A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

Lee's Pharmaceutical Limited n=1,617

NCT04015375 COMPLETED

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Torrent Pharmaceuticals Limited n=1,150

NCT02249767 COMPLETED

Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel

Spear Pharmaceuticals n=574

NCT02932306 COMPLETED

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=820

NCT01243450 COMPLETED

Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo

Spear Pharmaceuticals n=958

NCT02965456 COMPLETED

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc. n=820

NCT02189629 COMPLETED

CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris

Galderma R&D n=453

NCT02556788 COMPLETED

Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris

Galderma R&D n=1,212

NCT02566369 COMPLETED

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

Galderma R&D n=1,208

NCT01559922 COMPLETED

Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction

Suneva Medical, Inc. n=175

NCT01694433 COMPLETED

"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"

University of California, Los Angeles n=66

NCT03650361 COMPLETED

Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

Aleor Dermaceuticals Limited n=755

NCT01764308 TERMINATED

Effects of Omega-3 Fatty Acid Supplementation in Acne Patients

University of California, Los Angeles n=31

NCT02320149 COMPLETED

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Almirall, S.A. n=968

NCT03178994 COMPLETED

The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne

Chulalongkorn University n=42

NCT02413346 COMPLETED

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Almirall, S.A. n=490

NCT02322866 COMPLETED

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Almirall, S.A. n=1,034

NCT01974323 COMPLETED

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Almirall, S.A. n=2,238

NCT01974141 COMPLETED

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Almirall, S.A. n=2,102

NCT02886715 COMPLETED

A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Fougera Pharmaceuticals Inc. n=1,110

NCT01880320 COMPLETED

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Galderma R&D n=503

NCT01701024 COMPLETED

Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

Bausch Health Americas, Inc. n=498

NCT01445301 COMPLETED

Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects

GlaxoSmithKline n=800

NCT02465632 COMPLETED

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Glenmark Pharmaceuticals Ltd. India n=1,100

NCT00689117 COMPLETED

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Stiefel, a GSK Company n=1,649

NCT00891982 COMPLETED

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

Stiefel, a GSK Company n=60

NCT01017120 COMPLETED

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

Stiefel, a GSK Company n=742

NCT01910064 COMPLETED

A Long Term Study of GK530G in Subjects With Acne Vulgaris

Galderma R&D n=436

NCT02073448 COMPLETED

Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris.

Galderma R&D n=417

NCT03071549 COMPLETED

Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne

Cairo University n=34

NCT01915732 COMPLETED

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

GlaxoSmithKline n=1,018

NCT02173054 COMPLETED

An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne

Mahidol University n=120

NCT01017146 COMPLETED

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

Stiefel, a GSK Company n=744

NCT02865005 COMPLETED

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Seegpharm S.A. n=2,361

NCT00776919 COMPLETED

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Stiefel, a GSK Company n=1,315

NCT02160678 COMPLETED

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

G & W Laboratories Inc. n=1,741

NCT00818519 COMPLETED

GA YAZ ACNE in China Phase III

Bayer n=179

NCT01135069 COMPLETED

Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo

Spear Pharmaceuticals n=480

NCT01400932 COMPLETED

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

GlaxoSmithKline n=360

NCT00975143 COMPLETED

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Cipher Pharmaceuticals Inc. n=925

NCT01584674 COMPLETED

A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne

KLOX Technologies Inc. n=98

NCT00722761 COMPLETED

Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

Massachusetts General Hospital n=30

NCT01788384 COMPLETED

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Watson Laboratories, Inc. n=708

NCT01348321 COMPLETED

Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne

Ahvaz Jundishapur University of Medical Sciences n=169

NCT00838812 COMPLETED

Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate

Igefarma Laboratorios S.A. n=154

NCT06316297 RECRUITING

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Sanofi Pasteur, a Sanofi Company

NCT05891795 ACTIVE NOT RECRUITING

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

Stanford University

NCT07366229 RECRUITING

Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne

Shenzhen People's Hospital

NCT07504822 NOT YET RECRUITING

Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secretome Gel in the Improvement of Mild-to-Moderate Acne Vulgaris

Yohanes Firmansyah, dr, MH, MM

NCT07473895 NOT YET RECRUITING

Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study

Assiut University

NCT07449156 NOT YET RECRUITING

A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.

Shanghai Huaota Biopharmaceutical Co., Ltd.

NCT06374212 ACTIVE NOT RECRUITING

Anifrolumab for Hidradenitis Suppurativa

University of North Carolina, Chapel Hill

NCT02713607 ACTIVE NOT RECRUITING

Lipidome and Microbiome Profile of Acne

University of California, Davis

NCT07345390 NOT YET RECRUITING

Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris

Jiangxi Kvvit Pharmaceutical Co., Ltd.

NCT05080764 ACTIVE NOT RECRUITING

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults

Biofrontera Inc.

NCT07013747 RECRUITING

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Sanofi Pasteur, a Sanofi Company

NCT06925386 NOT YET RECRUITING

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Universitas Padjadjaran

NCT06770608 NOT YET RECRUITING

Various Procedural Treatment Options for Post-acne Atrophic Scars

Sheikh Zayed Medical College

NCT06311890 RECRUITING

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Xiyuan Hospital of China Academy of Chinese Medical Sciences

NCT04892706 COMPLETED

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

Bausch Health Americas, Inc.

NCT04856917 COMPLETED

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris

Vanda Pharmaceuticals

NCT04476043 COMPLETED

To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Incyte Corporation

NCT07015931 COMPLETED

Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V

Indonesia University

NCT05104125 COMPLETED

Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris

Ascletis Pharmaceuticals Co., Ltd.

NCT01474798 COMPLETED

Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris

Janssen Research & Development, LLC

NCT03852472 COMPLETED

Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)

Amgen

NCT01461655 COMPLETED

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

LEO Pharma

NCT02575950 COMPLETED

Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne

LEO Pharma

NCT06789874 COMPLETED

To Compare the Efficacy of Intralesional Saline Versus 35% Trichloracetic Acid (TCA) Peel in the Treatment of Atrophic Acne Scars

Sheikh Zayed Medical College

NCT05755256 COMPLETED

The Impact of Probiotics on Skin Hydration in Youth with Mild Acne

Lallemand Health Solutions

NCT05327361 TERMINATED

LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

University of Miami

NCT02404285 COMPLETED

A Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne

Next Science TM

NCT03752242 TERMINATED

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

BioMimetix JV, LLC

NCT03497897 COMPLETED

Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne

Novartis Pharmaceuticals

NCT06002854 COMPLETED

Comparison Of Outcome Of Microneedling With Autologous PRP Vs Microneedling With Topical Insulin In Treatment Of Post Acne Atrophic Scars.

Jinnah Postgraduate Medical Centre

NCT04019041 COMPLETED

A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa

Janssen Research & Development, LLC

NCT03076320 COMPLETED

Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

University of Guadalajara

NCT05926869 COMPLETED

Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris

Jinnah Postgraduate Medical Centre

NCT04092452 COMPLETED

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa

Pfizer

NCT02242760 COMPLETED

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Novan, Inc.

NCT05684861 COMPLETED

Serum TWEAK Levels in Acne Vulgaris

South Valley University

NCT04080869 COMPLETED

Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris

Assiut University

NCT02946788 COMPLETED

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

BioPharmX, Inc.

NCT02421172 COMPLETED

Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients

Novartis Pharmaceuticals

NCT02998671 COMPLETED

Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne

Novartis Pharmaceuticals

NCT04594759 COMPLETED

Weekly Isotretinoin Therapy Study

Medical University of South Carolina

NCT03573518 COMPLETED

Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Botanix Pharmaceuticals

NCT04899843 COMPLETED

Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

NCT04161456 COMPLETED

Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata

Dr. Frank Behrens

NCT03170388 COMPLETED

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc.

NCT04943159 COMPLETED

Afamelanotide in Patients Suffering With Acne Vulgaris

Clinuvel Pharmaceuticals Limited

NCT01616654 COMPLETED

Dose Range Study of CD5789 in Acne Vulgaris

Galderma R&D

NCT01936324 COMPLETED

A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

Dermira, Inc.

NCT02431052 COMPLETED

A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

Dermira, Inc.

NCT01490736 COMPLETED

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

Dermira, Inc.

NCT03599193 COMPLETED

A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris

Dr. Reddy's Laboratories Limited

NCT01213199 COMPLETED

Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Galderma R&D

NCT01106807 COMPLETED

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Galderma R&D

NCT01320033 COMPLETED

Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

Galderma R&D

NCT04104685 COMPLETED

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Vyne Therapeutics Inc.

NCT03034460 COMPLETED

Efficacy and Safety of CD5024 1% in Acne Vulgaris

Galderma R&D

NCT01831960 COMPLETED

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

Intrepid Therapeutics, Inc.

NCT02720627 COMPLETED

An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris

Cassiopea SpA

NCT01631474 COMPLETED

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

Intrepid Therapeutics, Inc.

NCT02938494 COMPLETED

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc.

NCT03341910 COMPLETED

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris

Dr. Reddy's Laboratories Limited

NCT04106778 COMPLETED

DMT310-003 Topical in the Treatment of Acne Vulgaris

Dermata Therapeutics

NCT03536637 COMPLETED

DMT310-001 Topical in the Treatment of Acne Vulgaris

Dermata Therapeutics

NCT04118296 COMPLETED

Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream

Sukma Skin Treatment

NCT04018885 COMPLETED

A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

NCT03275870 COMPLETED

Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa

Elena Gonzalez Brant, MD

NCT01326780 COMPLETED

A Study of a New Drug Treatment for Acne

Bausch Health Americas, Inc.

NCT02593383 COMPLETED

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

Lee's Pharmaceutical Limited

NCT02661958 COMPLETED

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

Sol-Gel Technologies, Ltd.

NCT03307577 COMPLETED

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

Therapeutics, Inc.

NCT02502669 COMPLETED

Finasteride Treatment of Severe Nodulocystic Acne

Elorac, Inc.

NCT01628549 COMPLETED

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Almirall, S.A.

NCT02656043 COMPLETED

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Xenon Pharmaceuticals Inc.

NCT01556698 COMPLETED

Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris

Novan, Inc.

NCT01844752 COMPLETED

A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne

Novan, Inc.

NCT02935036 COMPLETED

Efficacy Study in Patients With Acne Vulgaris.

Sun Pharmaceutical Industries, Inc.

NCT00765375 TERMINATED

Safety and Efficacy of the Use of Botox on Acne

DeNova Research

NCT03522922 COMPLETED

Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring

Sohag University

NCT03003247 COMPLETED

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Bausch Health Americas, Inc.

NCT02709096 COMPLETED

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

BioPharmX, Inc.

NCT02604680 COMPLETED

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Braintree Laboratories

NCT02796066 WITHDRAWN

TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris

Thesan Pharmaceuticals, Inc.

NCT02815332 COMPLETED

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris

BioPharmX, Inc.

NCT02656485 COMPLETED

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

AOBiome LLC

NCT02073461 COMPLETED

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

Galderma R&D

NCT02571998 COMPLETED

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Maruho Co., Ltd.

NCT01074502 TERMINATED

Apremilast in the Treatment of Moderate to Severe Acne

University of North Carolina, Chapel Hill

NCT00713609 COMPLETED

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Stiefel, a GSK Company

NCT02385760 COMPLETED

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

Celtaxsys, Inc.

NCT01115634 COMPLETED

Autologous Fibroblast Transplantation in Facial Deformities

Royan Institute

NCT02066545 COMPLETED

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Maruho Co., Ltd.

NCT02293018 COMPLETED

Pharmacokinetic Study of MTC896 Gel in Subjects With Acne

Mimetica Pty Limited

NCT01815450 COMPLETED

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Braintree Laboratories

NCT01657110 COMPLETED

Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne

The University of Western Australia

NCT01289574 COMPLETED

Topical ASC-J9 Cream for Acne

AndroScience Corp

NCT01160848 COMPLETED

Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients

Photocure

NCT02100527 WITHDRAWN

Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris

Pfizer

NCT01498874 COMPLETED

Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris

XOMA (US) LLC

NCT01347879 COMPLETED

A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris

Photocure

NCT00933543 COMPLETED

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Photocure

NCT01494285 COMPLETED

Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients

M. Arkin 1999 Ltd.

NCT01362010 COMPLETED

Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

Vyne Therapeutics Inc.

NCT00673933 COMPLETED

Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris

Photocure

NCT01293552 COMPLETED

Clinical Trial To Evaluate ANT-1207 In Subjects With Acne

Anterios Inc.

NCT00612573 COMPLETED

Treatment of Moderate to Severe Facial Acne Vulgaris

Warner Chilcott

NCT01644435 COMPLETED

A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

Kasiak Research Pvt. Ltd.

NCT01241331 COMPLETED

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Braintree Laboratories

NCT01194375 COMPLETED

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Dow Pharmaceutical Sciences

NCT00666900 COMPLETED

A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Dow Pharmaceutical Sciences

NCT00907335 COMPLETED

A Study of Acne Treatment in Children Ages 9 to 11

Bausch Health Americas, Inc.

NCT01180543 COMPLETED

Acne Treatment With Active Oplon's Patches

Oplon-Pure Science Ltd.

NCT00991198 COMPLETED

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

Aria Aesthetics Inc.

NCT01245946 COMPLETED

Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris

Pontificia Universidad Catolica de Chile

NCT01179633 COMPLETED

Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid

Oplon-Pure Science Ltd.

NCT06989840 RECRUITING

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Sagimet Biosciences Inc.

NCT06362889 NOT YET RECRUITING

Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy

Rejuva Medical Aesthetics

NCT07469228 COMPLETED

A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT06671834 COMPLETED

A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

Pfizer

NCT04321070 COMPLETED

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT01689935 COMPLETED

Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT)

Massachusetts General Hospital

NCT06454708 COMPLETED

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.

NCT06733402 COMPLETED

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT06673641 COMPLETED

A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.

Sun Pharmaceutical Industries, Inc.

NCT06468579 COMPLETED

To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

Suzhou Kintor Pharmaceutical Inc,

NCT05131373 COMPLETED

Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris

Sanofi Pasteur, a Sanofi Company

NCT06063473 COMPLETED

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT05428449 COMPLETED

Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029

Suzhou Kintor Pharmaceutical Inc,

NCT05012735 COMPLETED

A Study of a Hydrocolloid Bandage on Pimples

Johnson & Johnson Consumer Inc. (J&JCI)

NCT04044898 COMPLETED

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

NCT01704209 TERMINATED

Collagen Injections for the Treatment of Acne Scars and Wrinkles

Northwestern University

NCT02774590 COMPLETED

Timolol for the Treatment of Acne and Rosacea

Johns Hopkins University

NCT01830764 COMPLETED

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

Dermira, Inc.

NCT03743038 COMPLETED

A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

Vyne Therapeutics Inc.

NCT02250859 COMPLETED

A Pharmacokinetic Study of Minocycline in Male and Female Volunteers

Vyne Therapeutics Inc.

NCT04163263 COMPLETED

Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris

Boston Pharmaceuticals

NCT03709654 COMPLETED

A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne

Naked Biome, Inc.

NCT03450369 COMPLETED

A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne

Naked Biome, Inc.

NCT04059523 COMPLETED

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Sol-Gel Technologies, Ltd.

NCT01694810 COMPLETED

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Novan, Inc.

NCT04206631 COMPLETED

Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris

Indonesia University

NCT04134273 COMPLETED

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT03653403 COMPLETED

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

Bausch Health Americas, Inc.

NCT01688531 COMPLETED

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Galderma R&D

NCT01755247 COMPLETED

A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers

Novan, Inc.

NCT01773122 COMPLETED

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Allergan

NCT02250430 COMPLETED

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

Novan, Inc.

NCT01844739 COMPLETED

A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

Novan, Inc.

NCT02581072 COMPLETED

A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204

Novan, Inc.

NCT02801903 COMPLETED

Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris

Novan, Inc.

NCT02849873 COMPLETED

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Bausch Health Americas, Inc.

NCT02578043 COMPLETED

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02849860 COMPLETED

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

Bausch Health Americas, Inc.

NCT02850003 COMPLETED

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Bausch Health Americas, Inc.

NCT01428466 COMPLETED

Japanese Phase 1 Study of GSK2585823

GlaxoSmithKline

NCT01527123 COMPLETED

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

GlaxoSmithKline

NCT01929278 COMPLETED

W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers

Stiefel, a GSK Company

NCT01915758 COMPLETED

W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers

GlaxoSmithKline

NCT01019603 COMPLETED

A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris

Stiefel, a GSK Company

NCT01115322 COMPLETED

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

Stiefel, a GSK Company

NCT01112787 COMPLETED

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Stiefel, a GSK Company

NCT01132443 COMPLETED

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Stiefel, a GSK Company

NCT01114841 COMPLETED

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Stiefel, a GSK Company

NCT01119651 COMPLETED

A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers.

Stiefel, a GSK Company

NCT02498288 COMPLETED

A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition

GlaxoSmithKline

NCT01938482 COMPLETED

Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029

GlaxoSmithKline

NCT01984801 COMPLETED

Study to Investigate the Irritation Potential of GSK1940029 Gel

GlaxoSmithKline

NCT01769235 COMPLETED

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02709902 COMPLETED

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02411942 COMPLETED

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT01742637 COMPLETED

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02929719 COMPLETED

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02595034 COMPLETED

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02411955 COMPLETED

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT03132194 COMPLETED

Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT02218034 COMPLETED

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Allergan

NCT02164084 COMPLETED

A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

Novan, Inc.

NCT01769664 COMPLETED

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Sun Pharmaceutical Industries, Inc.

NCT01785836 WITHDRAWN

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Allergan

NCT01492647 COMPLETED

A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris

Janssen Pharmaceutical K.K.

NCT01425320 WITHDRAWN

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

Allergan

NCT01321645 COMPLETED

Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris

Miglani, Anjali

NCT01321632 COMPLETED

Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris

Miglani, Anjali

NCT01682200 COMPLETED

Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne

Medivet Pty Ltd

NCT01040390 COMPLETED

Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris

Miglani, Anjali

NCT01160757 COMPLETED

A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions

Arizona State University

NCT07544251 RECRUITING

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Integrative Skin Science and Research

NCT07524946 NOT YET RECRUITING

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

Bausch Health Americas, Inc.

NCT04582383 ACTIVE NOT RECRUITING

Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne

University of Pennsylvania

NCT07392047 NOT YET RECRUITING

Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris

Jinnah Postgraduate Medical Centre

NCT07384793 ACTIVE NOT RECRUITING

Comparison of Efficacy of Azithromycin Alone vs Combination of Azithromycin and Probiotics in Management of Mild to Moderate Acne Vulgaris

Hayatabad Medical Complex

NCT06425900 ACTIVE NOT RECRUITING

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

Sun Pharmaceutical Industries Limited

NCT07261072 NOT YET RECRUITING

Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Peking Union Medical College

NCT07102186 RECRUITING

Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris

Badr University

NCT06943118 NOT YET RECRUITING

Comparison of Efficacy of 35% Glycolic Acid vs 20% Salicylic Acid Peel in the Treatment of Post Acne Scars

Hayatabad Medical Complex

NCT06942468 NOT YET RECRUITING

Phenytoin in Treatment of Atrophic Post Acne Scars.

Assiut University

NCT03883269 RECRUITING

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

Centre for Human Drug Research, Netherlands

NCT07244887 COMPLETED

Randomized, Triple-Blind, Vehicle-Controlled Trial of Topical Dapsone Gel in Patients With Acne Vulgaris

Oya Helin Dundar

NCT07357337 COMPLETED

Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris

Ghurki Trust and Teaching Hospital

NCT06415305 COMPLETED

A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne

Sun Pharmaceutical Industries Limited

NCT06237465 WITHDRAWN

Botulinum Toxin-A for Hidradenitis Suppurativa

Yale University

NCT06336603 COMPLETED

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

Sun Pharmaceutical Industries Limited

NCT06336629 COMPLETED

A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

Sun Pharmaceutical Industries Limited

NCT06415279 COMPLETED

A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients

Sun Pharmaceutical Industries Limited

NCT06415292 COMPLETED

A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients

Sun Pharmaceutical Industries Limited

NCT04856904 COMPLETED

Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation

Galderma R&D

NCT05446402 COMPLETED

Investigation of the Tolerability of Two Facial Cleansing Routines for Mild to Moderate Acne

Northwestern University

NCT04548349 COMPLETED

Profiling the Skin Microbiome in Response to Altreno in Acne Patients

Beth Israel Deaconess Medical Center

NCT02755545 COMPLETED

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

Galderma R&D

NCT05089708 COMPLETED

AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

Galderma R&D

NCT04940767 COMPLETED

A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris

Edward Lain, MD

NCT05399290 COMPLETED

Subantimicrobial Doxycycline in Acne

Michigan State University

NCT05704114 COMPLETED

Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

Dr. Emmy Graber

NCT02899000 COMPLETED

A Treatment for Severe Inflammatory Acne Subjects

Galderma R&D

NCT02735421 COMPLETED

Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars

Galderma R&D

NCT05529888 COMPLETED

Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin.

Aswan University

NCT01807455 COMPLETED

An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine

Galderma R&D

NCT02249104 COMPLETED

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Galderma R&D

NCT01951417 COMPLETED

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Galderma R&D

NCT01909713 COMPLETED

Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.

Galderma R&D

NCT01522456 COMPLETED

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel

Galderma R&D

NCT01209949 COMPLETED

Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris

Galderma R&D

NCT03681470 COMPLETED

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

Icahn School of Medicine at Mount Sinai

NCT05096312 COMPLETED

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

East Avenue Medical Center, Philippines

NCT04451330 COMPLETED

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

Galderma R&D

NCT04300010 COMPLETED

Blue Light Therapy of C. Acnes

University of Wisconsin, Madison

NCT05216289 COMPLETED

The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne

Federal University of São Paulo

NCT03832647 COMPLETED

Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne

Vichy Laboratoires

NCT02457520 COMPLETED

ABSORICA in Patients With Severe Recalcitrant Nodular Acne

Sun Pharmaceutical Industries Limited

NCT03563365 TERMINATED

The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol

Yardley Dermatology Associates

NCT03630198 COMPLETED

Pain Outcomes Following Intralesional Corticosteroid Injections

Vanderbilt University Medical Center

NCT01138735 COMPLETED

Epiduo Pediatric Acne Study

Galderma R&D

NCT02589405 COMPLETED

Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

Galderma R&D

NCT00660985 COMPLETED

Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%

Galderma R&D

NCT01188538 COMPLETED

Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel

Galderma R&D

NCT02307266 COMPLETED

Patient Education in Adherence on Acne (PEAce)

Galderma R&D

NCT02959970 COMPLETED

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Almirall, S.A.

NCT02944461 COMPLETED

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Derm Research, PLLC

NCT03457636 COMPLETED

The Use of Oracea and Epiduo Forte in Severe Acne Patients

Derm Research, PLLC

NCT03402893 COMPLETED

The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color

Derm Research, PLLC

NCT02731105 COMPLETED

Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products

GWT-TUD GmbH

NCT01504204 COMPLETED

Effect of Samples on Acne Treatment With Epiduo® Gel

Wake Forest University

NCT01047189 COMPLETED

Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris

Wake Forest University

NCT02557399 COMPLETED

DUAC® Early Onset Efficacy Study in Japanese Subjects

GlaxoSmithKline

NCT03626298 COMPLETED

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

NCT01706263 COMPLETED

U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne

Stiefel, a GSK Company

NCT02695446 COMPLETED

Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

BioPharmX, Inc.

NCT02058628 COMPLETED

Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris

GlaxoSmithKline

NCT01706250 COMPLETED

U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™

Stiefel, a GSK Company

NCT00757523 COMPLETED

Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris

Stiefel, a GSK Company

NCT00964366 COMPLETED

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Stiefel, a GSK Company

NCT02524665 COMPLETED

8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne

Stiefel, a GSK Company

NCT01015638 COMPLETED

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Stiefel, a GSK Company

NCT01016977 COMPLETED

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

Stiefel, a GSK Company

NCT02721173 COMPLETED

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

All India Institute of Medical Sciences, Bhubaneswar

NCT00887484 COMPLETED

A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne

Stiefel, a GSK Company

NCT02647528 WITHDRAWN

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

Sadick Research Group

NCT00964223 COMPLETED

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Stiefel, a GSK Company

NCT02372786 COMPLETED

7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream

Erasmus Medical Center

NCT01613924 WITHDRAWN

Efficacy of Handheld Acne Heat Device

University of British Columbia

NCT02032407 COMPLETED

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Allergan

NCT00926367 COMPLETED

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Stiefel, a GSK Company

NCT01885910 COMPLETED

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Derm Research, PLLC

NCT00939133 COMPLETED

Proof of Concept Study to Investigate the Recurrence of Acne Post Isotretinoin

Dermatrials Research

NCT00748462 COMPLETED

Fractional CO2 Treatment of Acne Scars in Asians

Mahidol University

NCT01387048 COMPLETED

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin

University of Magdeburg

NCT01466673 COMPLETED

An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment

Janssen-Cilag Ltd.,Thailand

NCT01038869 COMPLETED

Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH)

Derm Research, PLLC

NCT01231334 COMPLETED

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Allergan

NCT00635609 COMPLETED

Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate

Warner Chilcott

NCT01149330 COMPLETED

Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

Galderma Brasil Ltda.

NCT01548898 COMPLETED

The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study

Cairo University

NCT00714714 COMPLETED

Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.

Bausch Health Americas, Inc.

NCT00907257 COMPLETED

A Study of Different Use Regimens Using Two Acne Treatments

Bausch Health Americas, Inc.

NCT00919191 COMPLETED

Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face

Bausch Health Americas, Inc.

NCT01313728 COMPLETED

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Bausch Health Americas, Inc.

NCT00952523 COMPLETED

Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face

Bausch Health Americas, Inc.

NCT01206348 COMPLETED

Combination Treatment for Moderate to Severe Acne

Medicis Global Service Corporation

NCT00835198 COMPLETED

Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris

Allergan

NCT00834210 COMPLETED

Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

Allergan

NCT01404130 COMPLETED

A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory

University of Aberdeen

Full Acne Pipeline

Every sponsor, every trial across Phase 1–4. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only